[1] Bahn RS, Dutton CM, Henfelder AE, et al. A genomic point mutation in the extracellular domain of the thyrotropin receptor in patients with Graves ophthalmopathy [J]. J Clin Endocrinol Metab,1994, 78(2): 256-60.[2] Stadlmayr W,Bichlmair AM, Spitzweg C,et al. Detection ofribonucleic acid encoding full length human thyrotropin receptor in orbital and pretibial fibroblast of patients with Graves ophthalmopathy and pretibial myxedema[J]. Thyroid, 1997, 7(1): 3-12.[3] Crisp MS, Lane C, Hallinoll M, et al. Thyrotropin receptor transcripts in human adipose tissue[J]. J Clin Endocrinol Metab, 1997, 82(6):2003-5.[4] Spitzweg C,Joba W, Hunt N, et al. Analysis of human thyrotropin receptor gene expression and immunoreactivity in human orbital tissue [J]. Eur J Endocrinol, 1997, 136(6): 599-607.[5] Major BJ, Cures A, Frauman AG. The full length and splice variant thyrotropin receptor is expressed exclusively in skeletal muscle of extraocular origin: a link to the pathogenesis of Graves ophthalmopathy[J]. Biochem Biophys Res Common, 1997, 230(3): 493-6.[6] Hiromatsu Y,Sato M,Inoue Y, et al. Localazation and clinical significance of thyrotropin receptor mRNA expression in orbital fat and eye muscle tissues from patients with thyroid-associated ophthalmopathy[J]. Thyroid, 1996, 6(6): 553-62. |